[{"ID":"5378_12-2021_NCT02432196","TOPIC_YEAR":2021,"RESPONSE":"$}}%>\n\nPlease select one of the options below:\n\nA: Eligible\nB: Excluded\nC: Irrelevant\n\nPlease select one of the options above by typing the corresponding letter (A, B, or C).","PROBA":0.9586980188},{"ID":"30612_65-2021_NCT01557465","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nFirst, we need to compare the patient's information to the inclusion criteria of the clinical trial. Based on the patient's note, the patient has type 1 diabetes, cardiomyopathy, and shortness of breath. None of these conditions are listed as inclusion criteria for the clinical trial. Therefore, we can conclude that the patient does not meet any of the inclusion criteria.\n\nNext, we need to compare the patient's information to the exclusion criteria of the clinical trial. The patient is not pregnant, and the patient is over 18 years old, so the patient does not meet any of the exclusion criteria.\n\nBased on the above analysis, we can conclude that the patient is excluded from the clinical trial. Therefore, the final answer is (B) excluded.","PROBA":0.9839223817},{"ID":"35572_75-2021_NCT02730065","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nFirst, we need to compare the patient's information with the inclusion criteria of the clinical trial. Based on the patient's note, the patient is a 55-year-old man with Parkinson's disease, Hoehn-Yahr Stage I, hypertension, and hypercholesterolemia. The patient does not have a history of stroke or dementia.\n\nNow, let's compare the patient's information with the exclusion criteria of the clinical trial. The patient does not have a history of stroke or dementia, which is in line with the exclusion criteria. However, the patient has Parkinson's disease, which is not explicitly listed as an exclusion criterion. Therefore, we need to determine if the patient's Parkinson's disease would preclude them from participating in the clinical trial.\n\nBased on the clinical trial's inclusion criteria, the patient's Parkinson's disease may not be a barrier to participation. The inclusion criteria specify that the patient must be stroke- and dementia-free, which the patient is. Additionally, the clinical trial is focused on cerebral small vessel disease, which is not directly related to Parkinson's disease. Therefore, we can conclude that the patient is eligible for the clinical trial.\n\nIn summary, the patient is eligible for the clinical trial because they do not have a history of stroke or dementia, and their Parkinson's disease is not explicitly listed as an exclusion criterion. Therefore, the answer is (A) eligible.","PROBA":0.9914406912},{"ID":"33729_71-2021_NCT02774668","TOPIC_YEAR":2021,"RESPONSE":"$}}%E2%80%8B%20Inclusion%20Criteria:%20\n\nPlease select one of the options in the bracket: {A: eligible, B: excluded, C: irrelevant}.","PROBA":0.9759249888},{"ID":"5443_12-2021_NCT03278574","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nFirst, we need to compare the patient's inclusion criteria with the clinical trial's inclusion criteria. Based on the patient's note, the patient has degenerative mitral valve disease and is planned for mitral valve repair. This aligns with the clinical trial's inclusion criteria, which includes patients undergoing mitral valve repair for degenerative mitral valve disease. Therefore, the patient satisfies the clinical trial's inclusion criteria.\n\nNext, we need to evaluate the patient's exclusion criteria. Based on the patient's note, there is no mention of previous open cardiac surgery, indication for concomitant aortic valve replacement, or left ventricle impairment (ejection fraction < 40%). Therefore, the patient does not meet any of the exclusion criteria.\n\nIn conclusion, based on the patient's note and the clinical trial's inclusion and exclusion criteria, the patient is eligible for the clinical trial. Therefore, I select option A: eligible.","PROBA":0.9891966243},{"ID":"35560_75-2021_NCT02657681","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nFirst, we need to compare the patient's information to the inclusion criteria.\n\nInclusion Criteria:\n\n* Diagnosis of Parkinson's disease (yes)\n* Hoehn-Yahr Stage I (yes)\n* No other main neuropsychiatric co-morbidity (yes)\n\nAll inclusion criteria are met.\n\nNext, we need to compare the patient's information to the exclusion criteria.\n\nExclusion Criteria:\n\n* MRI-incompatible metal objects in the body (no)\n\nThe patient does not have any MRI-incompatible metal objects in their body, so they do not meet any exclusion criteria.\n\nFinally, we can determine that the patient is eligible for the clinical trial.\n\n%Option A: eligible%\n\nPlease let me know if you have any questions or if there is anything else I can assist you with.","PROBA":0.9810003388},{"ID":"11642_17-2022_NCT01874132","TOPIC_YEAR":2022,"RESPONSE":"$}}%\n\nFirst, we need to compare the patient's information with the inclusion criteria. The patient is 67 years old, which is within the age range of 65-75 years old specified in the inclusion criteria. The patient has a history of slowly worsening vision in both eyes, which is not listed as an exclusion criterion. The patient's other medical history is unremarkable, which means they do not have any of the exclusion criteria such as non-smokers, non-morbidly obese, no history of severe hypertension, no history of falls, or no orthopaedic, neurological, pulmonary, or cardiac problems.\n\nNext, we need to evaluate the patient's physical examination findings. The patient has loss of the red reflex and blurry vision, which are consistent with the inclusion criteria of the study. The patient's blood pressure is 130\/70 and pulse is 68\/min, which are within the normal range specified in the inclusion criteria. The patient's other physical examinations are normal, which means they do not have any of the exclusion criteria such as orthopaedic, neurological, pulmonary, or cardiac problems.\n\nBased on the above information, the patient is eligible for the clinical trial. Therefore, the final summary is:\n\n{%A: eligible%}.","PROBA":0.9825899729},{"ID":"6816_15-2021_NCT02243007","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nPlease select one of the options in the bracket:\n\nA: eligible\nB: excluded\nC: irrelevant\n\nThank you!","PROBA":0.9979491201},{"ID":"5318_12-2021_NCT01708265","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nFirst, we will review the inclusion criteria. The patient must have severe organic mitral valve regurgitation and preserved left ventricular function. The patient's note states that she has severe mitral valve prolapse with regurgitation, which satisfies the inclusion criteria.\n\nNext, we will review the exclusion criteria. The patient must not have pulmonary hypertension (>50 mmHg at rest), atrial fibrillation, physical inability to undergo surgery, other life-threatening morbidity, higher expected surgical risks in advance, according to the dedicated heart team, moderate to severe kidney disease (eGFR less than 30 mL\/min), or flail leaflet together with a left ventricular end systolic diameter (LVESD) >40 mm. Based on the patient's note, there is no mention of pulmonary hypertension, atrial fibrillation, or physical inability to undergo surgery. However, the patient does have a history of gestational diabetes mellitus, hypertension with pregnancy, and obesity, which could be considered as moderate to severe kidney disease. Nevertheless, the patient's eGFR is not specified in the note, so we cannot determine if she meets the exclusion criterion of moderate to severe kidney disease. Additionally, the patient's LVESD is not specified, so we cannot determine if she meets the exclusion criterion of flail leaflet together with a left ventricular end systolic diameter (LVESD) >40 mm.\n\nTherefore, based on the information provided, we cannot definitively determine if the patient is eligible or excluded from the clinical trial. We need more information to make a final decision.\n\nPlease select one of the following options:\n\nA: eligible\nB: excluded\nC: irrelevant\n\nThank you for your time and assistance.","PROBA":0.9872841736},{"ID":"14106_30-2021_NCT02526719","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have Hashimoto's thyroiditis?\n\n#2. Is the patient undergoing mastectomy for breast cancer or risk reduction?\n\n#3. Does the patient have a BMI of 31 or greater?\n\n#4. Does the patient have a history of previous ipsilateral breast irradiation?\n\n#5. Does the patient have Regnault ptosis grade II or III?\n\n#6. Does the patient have a breast size of D cup or greater?\n\n#7. Is the patient an active smoker?\n\nPlease answer each question with either \"yes\" or \"no\" before moving on to the next question. Once you have answered all questions, please provide a final summary indicating whether the patient is eligible for the clinical trial (A: eligible, B: excluded, C: irrelevant).","PROBA":0.9904227698},{"ID":"17449_36-2021_NCT04835558","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nFirst, we will review the inclusion criteria:\n\nInclusion Criteria:\n\n* Obesity hypoventilation syndrome (OHS)\n* BMI \u226530 kg\/m2\n* Chronic daytime hypercapnia (PaCO2 >45 mm Hg)\n* Sleep-apnea in the absence of other known causes of hypercapnia\n\nNext, we will review the exclusion criteria:\n\nExclusion Criteria:\n\n* Severe respiratory disease\n* Subjects with orthopeadic and\/or neurologic disorders that could limit exercise tests\n\nNow, let's evaluate the patient's information against the inclusion and exclusion criteria:\n\n1. Obesity hypoventilation syndrome (OHS): Yes, the patient has OHS, as indicated by her symptoms of sleep apnea and hypercapnia.\n2. BMI \u226530 kg\/m2: Yes, the patient has a BMI of 41.54, which is greater than or equal to 30 kg\/m2.\n3. Chronic daytime hypercapnia (PaCO2 >45 mm Hg): Yes, the patient's PaCO2 level is 45 mm Hg, which is within the normal range.\n4. Sleep-apnea in the absence of other known causes of hypercapnia: Yes, the patient has sleep apnea and hypercapnia, and there are no other known causes of hypercapnia.\n\nNow, let's evaluate the patient's information against the exclusion criteria:\n\n1. Severe respiratory disease: No, the patient does not have a severe respiratory disease.\n2. Subjects with orthopeadic and\/or neurologic disorders that could limit exercise tests: No, the patient does not have any orthopeadic and\/or neurologic disorders that could limit exercise tests.\n\nBased on the above evaluation, the patient is eligible for the clinical trial. Therefore, the final summary is:\n\n{A: eligible}","PROBA":0.990298108},{"ID":"6690_15-2021_NCT01252719","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient have a history of CAD?\n\n#2. Does the patient have a recent abdominal mass?\n\n#3. Does the patient have fevers\/rigors and bandemia?\n\n#4. Does the patient have a history of diverticulitis?\n\n#5. Does the patient have a history of coronary artery disease?\n\n#6. Does the patient have a history of mitral valve prolapse?\n\n#7. Does the patient have a history of atrial fibrillation?\n\n#8. Does the patient have a history of hyperlipemia?\n\n#9. Does the patient have a history of hypertension?\n\n#10. Does the patient have a history of chronic kidney disease?\n\n#11. Does the patient have a history of hypothyroidism?\n\n#12. Does the patient have anemia?\n\n#13. Does the patient have a recent history of antibiotic use?\n\n#14. Does the patient have a history of allergic reaction to glycopeptides?\n\n#15. Is the patient unwilling to forego blood and\/or blood product donation?\n\nPlease answer the questions with a \"yes\" or \"no\" and I will determine the patient's eligibility for the clinical trial based on the answers.","PROBA":0.9909701438},{"ID":"17226_36-2021_NCT03082781","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nBased on the patient's note, here are the inclusion and exclusion criteria that are relevant to the clinical trial:\n\nInclusion Criteria:\n\n* Gender: Female\n* Age: 32 years old\n* BMI: 41.54 (obese)\n* No prior pregnancies\n* No history of CVD\n* No history of diabetes\n* No history of depression\n* No history of eating disorders\n* No chronic medications\n* No kidney disease\n* No cancer\n* No food allergies or intolerances\n\nExclusion Criteria:\n\n* History of CVD and other disorders such as diabetes, depression, eating disorders, chronic medications, kidney disease, cancer, food allergies or intolerances to items used in meals.\n* Subjects with abnormality in thyroid or Electrocardiograph\n* Any history of anti-obesity medication or weight loss drugs or dietary supplementations for weight control.\n\nBased on the patient's note, the patient meets all the inclusion criteria and does not meet any of the exclusion criteria. Therefore, the patient is eligible for the clinical trial.\n\nFinal Summary:\nThe patient is eligible for the clinical trial.\n\nOption: A (eligible)","PROBA":0.9887442632},{"ID":"6894_15-2021_NCT02984501","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nPlease select one of the options in the bracket:\n\nA. Eligible\nB. Excluded\nC. Irrelevant","PROBA":0.9600028037},{"ID":"13974_30-2021_NCT00677469","TOPIC_YEAR":2021,"RESPONSE":"$}}%>\n\nPlease select one of the options in the bracket:\n\n[A: eligible, B: excluded, C: irrelevant]","PROBA":0.9554720269},{"ID":"30893_65-2021_NCT03888664","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nFirst, we need to compare the patient's information to the inclusion criteria of the clinical trial. The inclusion criteria are:\n\n* Molecularly established FRDA\n* No clinically significant heart, liver, or kidney disease or other medically unstable conditions\n* No known sensitivity to \u03b3IFN\n* No previous exposure to recombinant hematopoietin\n\nBased on the patient's information, we can see that the patient has type 1 diabetes, cardiomyopathy, and is taking 70\/30 Insulin and vitamin D supplements. However, there is no mention of FRDA in the patient's note. Therefore, the patient does not meet the inclusion criterion of molecularly established FRDA and is not eligible for the clinical trial.\n\nSo, the final summary is:\n\n{%A: excluded%}\n\nPlease let me know if you have any further questions or if there's anything else I can help with.","PROBA":0.9884251919},{"ID":"5310_12-2021_NCT01635244","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nFirst, we need to compare the patient's inclusion criteria with the clinical trial's inclusion criteria. Based on the patient's note, the patient has Marfan's syndrome and severe mitral valve prolapse with regurgitation, which aligns with the clinical trial's inclusion criteria of severe aortic stenosis.\n\nNext, we need to evaluate the patient's exclusion criteria. The patient is not excluded based on age, as they are over 18 years old. The patient's aortic valve replacement is not urgent or emergent, and they do not have moderate or more aortic regurgitation on preoperative testing. The patient is willing and able to undergo preoperative echocardiography\/Doppler and post-operative exercise stress echocardiography\/Doppler for purposes of the research protocol. Therefore, the patient is eligible for the clinical trial.\n\nIn conclusion, the patient is eligible for the clinical trial based on the inclusion and exclusion criteria provided. Therefore, I select option A: eligible.","PROBA":0.9928353396},{"ID":"17033_36-2021_NCT01492413","TOPIC_YEAR":2021,"RESPONSE":"$}}%EOF\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n","PROBA":0.9998594955},{"ID":"6712_15-2021_NCT01442441","TOPIC_YEAR":2021,"RESPONSE":"$}}%\n\nFirst, we will review the inclusion criteria:\n\nInclusion Criteria:\n\n1. Patients with suspected chronic pancreatitis\n\nThe patient's note mentions a recent history of abdominal pain and a large heterogeneous mass in the left upper abdomen, consistent with pancreatic adenocarcinoma at the head of the pancreas. These symptoms and findings suggest that the patient may have chronic pancreatitis. Therefore, the patient meets the inclusion criterion.\n\nNext, we will review the exclusion criteria:\n\nExclusion Criteria:\n\n1. Patients who are less than 18 years old\n\nThe patient's note does not mention the patient's age, so we cannot determine if the patient is under 18 years old. Therefore, we cannot exclude the patient based on this criterion.\n\nFinally, we will review the patient's medical history:\n\nThe patient's medical history includes coronary artery disease, mitral valve prolapse, atrial fibrillation, hyperlipemia, hypertension, chronic kidney disease, hypothyroidism, and anemia. None of these conditions are exclusion criteria for the clinical trial.\n\nBased on the information provided, the patient is eligible for the clinical trial. Therefore, the final summary is:\n\n{%A: eligible%}","PROBA":0.9868890192},{"ID":"33899_71-2021_NCT04197817","TOPIC_YEAR":2021,"RESPONSE":"#1. Does the patient meet the inclusion criteria?\n\n#2. Does the patient meet the exclusion criteria?\n\n#3. Is there any reason why the patient should not participate in the clinical trial?\n\nPlease select one of the options in the bracket after each question.\n\nThank you!","PROBA":0.9900757619}]
